Aeequs Pharmaceuticals is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus’ sales and marketing efforts are based in Canada, targeting highly specialized therapeutic areas including ophthalmology and transplant.

We continue to build pipeline in ophthalmology and we have recently added a number of commercial stage products through in-licensing agreements. Our commercial infrastructure with specialty sales representatives is currently promoting two specialty medicines to physicians and two over the counter (“OTC”) products to eye care professionals.

Our commercial programs are supported and validated by insights from patients, physicians, and payers to ensure there is a realizable benefit for them from our work in advancing these products. Aequus’ management team has a proven track record of successfully managing the required clinical development, regulatory approval processes, and marketing of products either directly or through collaborations. We continue to leverage our internal capabilities and know-how to execute an efficient commercial strategy and development plan to drive shareholder value.